Stocktoria
Outset Medical, Inc. OM
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2020-09-15
Outset Medical, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 39.1% | 33.9% | 22.2% | 15.5% | 7.4% |
| Operating margin | -55.8% | -99.7% | -130.2% | -139.6% | -127.2% |
| Net margin | -68.3% | -112.6% | -132.5% | -141.2% | -128.6% |
| FCF margin | -39.4% | -103.1% | -103.4% | -133.5% | -130.0% |
| Return on assets | -30.9% | -46.4% | -55.1% | -40.7% | -28.5% |
| Return on equity | -64.3% | -477.2% | -140.6% | -66.2% | -35.3% |
| Debt / equity | 0.76× | 7.36× | 1.06× | 0.39× | 0.08× |
| Current ratio | 6.67 | 5.69 | 5.26 | 7.19 | 7.93 |
| Revenue growth | 5.1% | -12.8% | 13.0% | 12.4% | 105.5% |
Source: SEC EDGAR filings · CIK 0001484612 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.